Blondet Juan J, Carlson Annelisa M, Kobayashi Takashi, Jie Tun, Bellin Melena, Hering Bernhard J, Freeman Martin L, Beilman Greg J, Sutherland David E R
Division of Surgical Critical Care/Trauma, Department of Surgery, University of Minnesota, MMC 11, 420 Delaware Street Southeast, Minneapolis, MN 55455, USA.
Surg Clin North Am. 2007 Dec;87(6):1477-501, x. doi: 10.1016/j.suc.2007.08.014.
Total pancreatectomy and islet autotransplantation are done for chronic pancreatitis with intractable pain when other treatment measures have failed, allowing insulin secretory capacity to be preserved, minimizing or preventing diabetes, while at the same time removing the root cause of the pain. Since the first case in 1977, several series have been published. Pain relief is obtained in most patients, and insulin independence preserved long term in about a third, with another third having sufficient beta cell function so that the surgical diabetes is mild. Islet autotransplantation has been done with partial or total pancreatectomy for benign and premalignant conditions. Islet autotransplantation should be used more widely to preserve beta cell mass in major pancreatic resections.
当其他治疗措施失败时,对于伴有顽固性疼痛的慢性胰腺炎患者,可进行全胰切除术和胰岛自体移植,这样既能保留胰岛素分泌能力,将糖尿病降至最低程度或预防糖尿病,同时又能消除疼痛的根源。自1977年首例手术以来,已有多个系列报道。大多数患者疼痛得到缓解,约三分之一的患者长期保持胰岛素非依赖状态,另有三分之一患者具有足够的β细胞功能,使得术后糖尿病症状较轻。胰岛自体移植已用于良性和癌前病变的部分或全胰切除术中。在主要的胰腺切除术中,应更广泛地应用胰岛自体移植以保留β细胞量。